| Financial Year |
March 31 2023 |
| Monetary Funds |
158,092,744.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
281,130,006.90 |
| Advances to Suppliers |
23,254,509.81 |
| Other Receivables |
10,717,992.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
757,841,400.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,317,265.09 |
| Total Current Assets |
1,339,861,279.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
723,825,292.29 |
| Under-construction Projects |
21,856,274.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,487,656.58 |
| R&D expenses |
-- |
| Goodwill |
28,812,837.76 |
| Long-Term Deferred and Prepaid Expenses |
13,760,264.63 |
| Deferred Income Tax Assets |
8,739,975.16 |
| Other Non-Current Assets |
6,653,532.57 |
| Sub-Total of Non-Current Assets |
930,374,003.65 |
| Total Assets |
2,270,235,283.29 |
| Short-Term Loans |
480,360,460.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
227,197,512.84 |
| Accounts Payable |
50,447,351.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,013,490.99 |
| Taxes Payable |
2,755,726.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,174,641.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,232,529.37 |
| Other Current Liabilities |
3,468,186.62 |
| Sub-Total of Current Liabilities |
889,602,290.73 |
| Long-term Loans |
128,620,000.00 |
| Bonds Payable |
283,629,470.26 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
738,301.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
425,022,017.47 |
| Total Liabilities |
1,314,624,308.20 |
| Paid-In Capital(Or Share Stock) |
277,642,573.00 |
| Capital Surplus |
230,000,282.58 |
| Surplus Reserve |
53,913,423.70 |
| LESS:Treasury Stock |
14,834,520.00 |
| Undistributed Profits |
318,804,731.04 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
955,610,975.09 |
| Owner's Equity（Stockholder's Equity） |
955,610,975.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,270,235,283.29 |
